Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,640 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 20 | N/A | N/A | N/A | N/A |
| Other Working Capital | -440 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 120 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-1,940 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 1,731 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,730 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $5 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,710 | N/A | N/A | N/A | N/A |
| End Cash Position | 1,500 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $-210 | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,940 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,940 | 0 | 0 | 0 | 0 |